Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1

Status

Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

pegylated granulocyte colony-stimulating factor 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × Breastcancer × Clear all
NCT03121248 2023-12-22

HAI-5-III

University Hospital, Ghent

Phase NA Active not recruiting
144 enrolled
Breast

Breastcancer

NCT02996240 2021-03-17

Breast, Omega 3 Free Fatty Acid, Ph 0

The University of Texas Health Science Center at San Antonio

Phase NA Completed
21 enrolled
Breast

Breastcancer

NCT02975128 2020-05-29

BLES

Radboud University Medical Center

Phase NA Terminated
22 enrolled
Breast

Breastcancer

NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Peking University

Phase 4 Completed
240 enrolled
Breast

Breastcancer

NCT02967146 2017-01-05

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Samsung Medical Center

Phase 3 Unknown
170 enrolled
Breast

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡